Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
GoodRx goes toe-to-toe with Hims, Ro as it pushes into ED treatment
5 weeks ago
Pharma
Health Tech
Former a16z biotech investment leader Vijay Pande exits the VC firm
5 weeks ago
People
Exclusive: Scorpion spinout gets $177M for stealthy pipeline amid China competition
5 weeks ago
Financing
Startups
Recursion to lay off 20% of staff, a month after slashing its pipeline
5 weeks ago
People
AI
Odyssey pulls back from IPO plans as public markets remain frozen
5 weeks ago
Financing
Startups
Updated: HHS chief Kennedy removes all ACIP members, dismantling vaccine board
Last month
Pharma
FDA+
Biotech slump forces Resilience to wind down six manufacturing sites, using bankruptcy move
Last month
People
Manufacturing
FDA reinstates generic drug policy group let go in April firings
Last month
FDA+
Former HHS lawyer on Novavax delay: Mixing politics and approvals 'imperils' public health
Last month
FDA+
FDA adds biomarker limits to stomach, esophageal cancer labels for Merck's Keytruda and BMS' Opdivo
Last month
Pharma
FDA+
Updated: Merck wins FDA approval for RSV antibody drug, making a hot market more competitive
Last month
R&D
Pharma
In a break from other biotechs, Twist Bioscience throws support behind tariffs on synthetic DNA
Last month
Pharma
Manufacturing
Federally-funded cancer research comes to a perilous crossroads
Last month
Bioregnum
R&D
Merck says its oral PCSK9 inhibitor ‘significantly’ cut cholesterol in two Phase 3 trials
Last month
R&D
NewAmsterdam's experimental cholesterol drug reduces presence of Alzheimer's biomarker
Last month
R&D
Avidity to seek accelerated approval for FSHD drug; Axsome to run another trial
Last month
News Briefing
Metsera shares early data on anti-obesity amylin candidate
Last month
Startups
R&D
Who are the women reshaping biopharma R&D? Nominate them for Endpoints' annual report
Last month
Special
Sanofi leans into 'first-mover advantage' by shipping Beyfortus early, as RSV antibody market set to heat up
Last month
Pharma
Manufacturing
Highlights from #ASCO25; Biotech’s icy market; Sanofi’s $9B acquisition; and more
Last month
Weekly
EMA considers serious eye condition a ‘very rare’ side effect of semaglutide
Last month
Pharma
FDA+
Updated: Omada Health rose 21% in its public market debut
Last month
Financing
Health Tech
Is there still hope for Summit's cancer drug buried in the data?
Last month
R&D
Kelun's $250M PIPE; Valneva moves chikungunya vaccine to Phase 3 for kids
Last month
News Briefing
First page
Previous page
9
10
11
12
13
14
15
Next page
Last page